US Stock MarketDetailed Quotes

GEMP Gemphire Therapeutics

Watchlist
  • 0.000
  • 0.0000.00%
Close Dec 20 09:30 ET
0Market Cap0.00P/E (TTM)

Gemphire Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
5.90%-2.36M
24.25%-2.72M
21.36%-4.83M
-40.60%-15.13M
-23.47%-2.9M
-28.30%-2.51M
-54.35%-3.59M
-48.41%-6.14M
-52.92%-10.76M
-83.72%-2.35M
Net income from continuing operations
10.05%-3.11M
15.76%-3.3M
13.51%-2.88M
48.50%-15.28M
76.54%-4.58M
-13.33%-3.46M
-64.47%-3.92M
29.73%-3.32M
-39.25%-29.68M
-46.41%-19.51M
Operating gains losses
--0
----
----
----
----
----
----
----
----
----
Depreciation and amortization
-83.33%2K
-58.33%5K
0.00%12K
4.35%48K
0.00%12K
9.09%12K
0.00%12K
9.09%12K
170.59%46K
0.00%12K
Other non cash items
--0
-71.43%2K
20.00%6K
-99.86%24K
-99.97%6K
0.00%6K
40.00%7K
0.00%5K
41.37%17.36M
41.82%17.34M
Change In working capital
-35.59%534K
117.04%293K
27.87%-2.18M
-172.19%-584K
516.10%1.47M
-5.15%829K
205.47%135K
-824.46%-3.02M
8.74%809K
71.29%-354K
-Change in prepaid assets
160.56%370K
634.38%513K
-469.81%-1.51M
1,100.00%396K
60.16%615K
-64.50%142K
-121.29%-96K
77.95%-265K
-96.00%33K
852.94%384K
-Change in payables and accrued expense
-76.13%164K
-195.24%-220K
75.73%-669K
-226.29%-980K
216.26%858K
44.94%687K
139.90%231K
-270.23%-2.76M
1,070.00%776K
37.56%-738K
Cash from discontinued investing activities
Operating cash flow
5.90%-2.36M
24.25%-2.72M
21.36%-4.83M
-40.60%-15.13M
-23.47%-2.9M
-28.30%-2.51M
-54.35%-3.59M
-48.41%-6.14M
-52.92%-10.76M
-83.72%-2.35M
Investing cash flow
Cash flow from continuing investing activities
0
-949.28%-586K
-921.13%-583K
0
101.14%69K
101.20%71K
Net PPE purchase and sale
--0
----
----
25.00%-3K
--0
--0
----
----
98.13%-4K
97.92%-2K
Net other investing changes
----
----
----
-898.63%-583K
----
----
----
----
100.99%73K
----
Cash from discontinued investing activities
Investing cash flow
--0
366.67%8K
--0
-949.28%-586K
-921.13%-583K
--0
---3K
--0
101.14%69K
101.20%71K
Financing cash flow
Cash flow from continuing financing activities
-458.33%-134K
0
0
221.17%22.03M
12.89M
-24K
-98.94%72K
17,054.72%9.09M
-71.62%6.86M
0
Net common stock issuance
--0
--0
--0
220.00%24M
--14M
--0
--0
--10M
--7.5M
--0
Proceeds from stock option exercised by employees
--0
----
----
116.98%115K
--43K
--0
----
----
5,200.00%53K
--0
Net other financing activities
----
----
----
-200.58%-2.09M
---1.16M
---24K
--0
---908K
-839.19%-695K
--0
Cash from discontinued financing activities
Financing cash flow
-458.33%-134K
--0
--0
221.17%22.03M
--12.89M
---24K
-98.94%72K
17,054.72%9.09M
-71.62%6.86M
--0
Net cash flow
Beginning cash position
-6.98%8.85M
-11.34%11.56M
62.42%16.39M
-27.54%10.09M
-43.46%6.98M
-33.47%9.51M
32.82%13.04M
-27.54%10.09M
389.38%13.92M
-41.52%12.35M
Current changes in cash
1.50%-2.49M
23.00%-2.71M
-263.64%-4.83M
264.35%6.31M
513.00%9.4M
-29.53%-2.53M
-178.51%-3.52M
172.20%2.95M
-134.66%-3.84M
68.45%-2.28M
Effect of exchange rate changes
--0
125.00%1K
80.00%-1K
-366.67%-8K
-107.69%-1K
-77.78%2K
-233.33%-4K
77.27%-5K
-57.14%3K
-7.14%13K
End cash Position
-8.99%6.36M
-6.98%8.85M
-11.34%11.56M
62.42%16.39M
62.42%16.39M
-43.46%6.98M
-33.47%9.51M
32.82%13.04M
-27.54%10.09M
-27.54%10.09M
Free cash flow
5.90%-2.36M
24.32%-2.72M
21.36%-4.83M
-40.57%-15.14M
-23.36%-2.9M
-28.30%-2.51M
-54.48%-3.59M
-48.33%-6.14M
-48.46%-10.77M
-71.03%-2.35M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 5.90%-2.36M24.25%-2.72M21.36%-4.83M-40.60%-15.13M-23.47%-2.9M-28.30%-2.51M-54.35%-3.59M-48.41%-6.14M-52.92%-10.76M-83.72%-2.35M
Net income from continuing operations 10.05%-3.11M15.76%-3.3M13.51%-2.88M48.50%-15.28M76.54%-4.58M-13.33%-3.46M-64.47%-3.92M29.73%-3.32M-39.25%-29.68M-46.41%-19.51M
Operating gains losses --0------------------------------------
Depreciation and amortization -83.33%2K-58.33%5K0.00%12K4.35%48K0.00%12K9.09%12K0.00%12K9.09%12K170.59%46K0.00%12K
Other non cash items --0-71.43%2K20.00%6K-99.86%24K-99.97%6K0.00%6K40.00%7K0.00%5K41.37%17.36M41.82%17.34M
Change In working capital -35.59%534K117.04%293K27.87%-2.18M-172.19%-584K516.10%1.47M-5.15%829K205.47%135K-824.46%-3.02M8.74%809K71.29%-354K
-Change in prepaid assets 160.56%370K634.38%513K-469.81%-1.51M1,100.00%396K60.16%615K-64.50%142K-121.29%-96K77.95%-265K-96.00%33K852.94%384K
-Change in payables and accrued expense -76.13%164K-195.24%-220K75.73%-669K-226.29%-980K216.26%858K44.94%687K139.90%231K-270.23%-2.76M1,070.00%776K37.56%-738K
Cash from discontinued investing activities
Operating cash flow 5.90%-2.36M24.25%-2.72M21.36%-4.83M-40.60%-15.13M-23.47%-2.9M-28.30%-2.51M-54.35%-3.59M-48.41%-6.14M-52.92%-10.76M-83.72%-2.35M
Investing cash flow
Cash flow from continuing investing activities 0-949.28%-586K-921.13%-583K0101.14%69K101.20%71K
Net PPE purchase and sale --0--------25.00%-3K--0--0--------98.13%-4K97.92%-2K
Net other investing changes -------------898.63%-583K----------------100.99%73K----
Cash from discontinued investing activities
Investing cash flow --0366.67%8K--0-949.28%-586K-921.13%-583K--0---3K--0101.14%69K101.20%71K
Financing cash flow
Cash flow from continuing financing activities -458.33%-134K00221.17%22.03M12.89M-24K-98.94%72K17,054.72%9.09M-71.62%6.86M0
Net common stock issuance --0--0--0220.00%24M--14M--0--0--10M--7.5M--0
Proceeds from stock option exercised by employees --0--------116.98%115K--43K--0--------5,200.00%53K--0
Net other financing activities -------------200.58%-2.09M---1.16M---24K--0---908K-839.19%-695K--0
Cash from discontinued financing activities
Financing cash flow -458.33%-134K--0--0221.17%22.03M--12.89M---24K-98.94%72K17,054.72%9.09M-71.62%6.86M--0
Net cash flow
Beginning cash position -6.98%8.85M-11.34%11.56M62.42%16.39M-27.54%10.09M-43.46%6.98M-33.47%9.51M32.82%13.04M-27.54%10.09M389.38%13.92M-41.52%12.35M
Current changes in cash 1.50%-2.49M23.00%-2.71M-263.64%-4.83M264.35%6.31M513.00%9.4M-29.53%-2.53M-178.51%-3.52M172.20%2.95M-134.66%-3.84M68.45%-2.28M
Effect of exchange rate changes --0125.00%1K80.00%-1K-366.67%-8K-107.69%-1K-77.78%2K-233.33%-4K77.27%-5K-57.14%3K-7.14%13K
End cash Position -8.99%6.36M-6.98%8.85M-11.34%11.56M62.42%16.39M62.42%16.39M-43.46%6.98M-33.47%9.51M32.82%13.04M-27.54%10.09M-27.54%10.09M
Free cash flow 5.90%-2.36M24.32%-2.72M21.36%-4.83M-40.57%-15.14M-23.36%-2.9M-28.30%-2.51M-54.48%-3.59M-48.33%-6.14M-48.46%-10.77M-71.03%-2.35M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.